DE69904465D1 - Therapie von depressionen - Google Patents

Therapie von depressionen

Info

Publication number
DE69904465D1
DE69904465D1 DE69904465T DE69904465T DE69904465D1 DE 69904465 D1 DE69904465 D1 DE 69904465D1 DE 69904465 T DE69904465 T DE 69904465T DE 69904465 T DE69904465 T DE 69904465T DE 69904465 D1 DE69904465 D1 DE 69904465D1
Authority
DE
Germany
Prior art keywords
therapy
depressions
antidepressant
delivering
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69904465T
Other languages
English (en)
Other versions
DE69904465T2 (de
Inventor
D Ayer
Sylvia Seroff
S-L Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DE69904465D1 publication Critical patent/DE69904465D1/de
Publication of DE69904465T2 publication Critical patent/DE69904465T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69904465T 1998-05-14 1999-05-07 Therapie von depressionen Expired - Fee Related DE69904465T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8543298P 1998-05-14 1998-05-14
PCT/US1999/009917 WO1999058115A1 (en) 1998-05-14 1999-05-07 Antidepressant therapy

Publications (2)

Publication Number Publication Date
DE69904465D1 true DE69904465D1 (de) 2003-01-23
DE69904465T2 DE69904465T2 (de) 2003-10-02

Family

ID=22191553

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69904465T Expired - Fee Related DE69904465T2 (de) 1998-05-14 1999-05-07 Therapie von depressionen

Country Status (11)

Country Link
US (1) US20010055614A1 (de)
EP (1) EP1077683B1 (de)
JP (1) JP2002514592A (de)
AT (1) ATE229326T1 (de)
AU (1) AU3885799A (de)
CA (1) CA2331542A1 (de)
DE (1) DE69904465T2 (de)
DK (1) DK1077683T3 (de)
ES (1) ES2187156T3 (de)
PT (1) PT1077683E (de)
WO (1) WO1999058115A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0707127D0 (en) * 2007-04-13 2007-05-23 Zysis Ltd Pharmaceutical compositions
LT2501234T (lt) 2009-11-20 2017-12-11 Tonix Pharma Holdings Limited Būdai ir kompozicijos, skirti simptomų, susijusių su potrauminiu streso sutrikimu, gydymui naudojant ciklobenzapriną
JP2013524275A (ja) * 2010-04-03 2013-06-17 ドシ，プラフル 薬剤を含む医療機器、その製造方法とその使用方法
US20110319389A1 (en) 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US11998516B2 (en) 2011-03-07 2024-06-04 Tonix Pharma Holdings Limited Methods and compositions for treating depression using cyclobenzaprine
WO2013188847A1 (en) * 2012-06-15 2013-12-19 Tonix Pharmaceuticals, Inc. Compositions and methods for transmucosal absorption
HRP20240648T1 (hr) 2013-03-15 2024-08-02 Tonix Pharma Holdings Limited Eutektičke formulacije ciklobenzaprin hidroklorida i manitola
JP7064285B2 (ja) * 2013-12-06 2022-05-10 デュレクト コーポレーション 抗酸化剤を含む組成物、流体分注器、及びそれらに関わる方法
CA2961822A1 (en) 2014-09-18 2016-03-24 Tonix Pharma Holdings Limited Eutectic formulations of cyclobenzaprine hydrochloride
CN118267382A (zh) 2017-12-11 2024-07-02 通尼克斯制药控股有限公司 用于痴呆和神经变性病况中的激越、精神病和认知衰退的环苯扎林治疗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US5591454A (en) * 1989-09-05 1997-01-07 Alza Corporation Method for lowering blood glucose
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
EP0640341A1 (de) * 1993-08-27 1995-03-01 Mitsui Toatsu Chemicals, Incorporated Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren

Also Published As

Publication number Publication date
ATE229326T1 (de) 2002-12-15
EP1077683B1 (de) 2002-12-11
CA2331542A1 (en) 1999-11-18
EP1077683A1 (de) 2001-02-28
US20010055614A1 (en) 2001-12-27
JP2002514592A (ja) 2002-05-21
PT1077683E (pt) 2003-04-30
WO1999058115A1 (en) 1999-11-18
DK1077683T3 (da) 2003-03-31
ES2187156T3 (es) 2003-05-16
DE69904465T2 (de) 2003-10-02
AU3885799A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
PT913156E (pt) Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
FI925342A (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
ATE249238T1 (de) Verwendung von thrombin-derivierten peptiden zur therapie von kardiovaskuläre krankheiten
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
PT946151E (pt) Forma de dosagem de dose crescente
DE69904465D1 (de) Therapie von depressionen
PT998287E (pt) Utilizacao de levobupivacaina
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
PT981347E (pt) Utilizacao de levobupivacaina em cirurgia facial
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
SE9601395D0 (sv) New therapeutic treatment 1
SE9902597D0 (sv) New use
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
TR200401810T4 (tr) Kısırlık tedavisinde fsh'ın kullanılması
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
SE9800139D0 (sv) New use
TR200000461T2 (tr) Bir transdermal terapötik sistemin suistimalinin önlenmesini sağlayan işlem.
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
RU2000110676A (ru) Способ консервативного лечения стриктур уретры

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee